Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Long-Term Investments (2020 - 2026)

Bioventus filings provide 6 years of Long-Term Investments readings, the most recent being $2.3 million for Q4 2025.

  • On a quarterly basis, Long-Term Investments rose 21.19% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 million, a 21.19% increase, with the full-year FY2025 number at $2.3 million, up 21.19% from a year prior.
  • Long-Term Investments hit $2.3 million in Q4 2025 for Bioventus, up from $2.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $78.5 million in Q3 2022 to a low of $1.7 million in Q2 2025.
  • Median Long-Term Investments over the past 5 years was $3.2 million (2023), compared with a mean of $12.3 million.
  • Biggest five-year swings in Long-Term Investments: soared 302.84% in 2022 and later tumbled 91.67% in 2023.
  • Bioventus' Long-Term Investments stood at $16.8 million in 2021, then tumbled by 84.37% to $2.6 million in 2022, then grew by 19.84% to $3.1 million in 2023, then plummeted by 39.76% to $1.9 million in 2024, then increased by 21.19% to $2.3 million in 2025.
  • The last three reported values for Long-Term Investments were $2.3 million (Q4 2025), $2.3 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.